Raleigh, NC, United States of America

Randolph B DePrince

This inventor holds 8 USPTO granted patents and 2 published patent applications. Top assignees: Amgen Inc., Glaxo Group Limited, Gilead Sciences, Inc.. Active years: 1998-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Randolph B DePrince. Retrieved from https://idiyas.com/inventor/randolph-b-deprince

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 75.0

Average Co-Inventor Count = 5.7

ph-index = 6

Forward Citations = 618(Granted Patents)


Company Filing History:


Years Active: 1998-2012

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovations of Randolph B DePrince

Introduction

Randolph B DePrince is a notable inventor based in Raleigh, NC (US), recognized for his contributions to the field of protein chemistry. With a total of 8 patents to his name, he has made significant advancements in the modification of proteins, particularly through the attachment of water-soluble polymers.

Latest Patents

His latest patents include innovative methods and compositions related to N-terminally chemically modified protein compositions. These patents detail novel techniques for modifying proteins or their analogs, resulting in compositions such as N-terminally chemically modified G-CSF and chemically modified consensus interferon. These advancements have the potential to enhance the efficacy of therapeutic proteins.

Career Highlights

Throughout his career, Randolph B DePrince has worked with prominent companies in the biotechnology sector, including Amgen Inc. and Glaxo Group Limited. His work in these organizations has allowed him to develop and refine his innovative approaches to protein modification.

Collaborations

Some of his notable coworkers include Olaf B Kinstler and Nancy E Gabriel, who have collaborated with him on various projects, contributing to the advancement of protein chemistry.

Conclusion

Randolph B DePrince's work exemplifies the intersection of innovation and biotechnology, showcasing his commitment to enhancing protein therapies through his patented methods. His contributions continue to influence the field and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…